BAKER BROS. ADVISORS LP Q2 2023 Filing
Filed August 14, 2023
Portfolio Value
$17.3B
Holdings
107
Report Date
Q2 2023
Filing Type
13F-HR
All Holdings (107 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | FGENEURFibroGen, Inc. | 238,084 | $642.0M | 3.72% | |
| 102 | NKTXNkarta, Inc. | 271,329 | $594.0M | 3.44% | |
| 103 | TARAProtara Therapeutics, Inc. | 199,671 | $477.0M | 2.76% | |
| 104 | —Genetron Holdings Limited | 455,306 | $423.0M | 2.45% | |
| 105 | FHTXFoghorn Therapeutics Inc. | 45,027 | $316.0M | 1.83% | |
| 106 | —Vincerx Pharma, Inc. | 225,579 | $293.0M | 1.70% | |
| 107 | SRZNWSurrozen, Inc. | 833,333 | $46.0M | 0.27% |
PreviousPage 2 of 2